Clinical Trial Update: Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis [Phase 3]

View source ↗

Summary

Phase 3 trial update for pimavanserin in dementia-related psychosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia-related Psychosis

Drugs mentioned

• Pimavanserin (pimavanserin)

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Dementia-related Psychosis | Phase 3 | Status: COMPLETED | Results posted: 2021-06-21